Delivery Order SPE2DB24D2012-SPE2DB25FBWDP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,802.62 to AmerisourceBergen Drug Corp for the supply of epinephrine 0.3 mg auto-injector units (two-pack). The contract was competitively awarded on June 20, 2025, with an ultimate completion date of June 23, 2025, utilizing firm fixed-price pricing with no set-aside designation. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,865.81 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 MG auto-injector two-packs. This competitive award, with an ultimate completion date of September 3, 2025, was issued as a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,652.22 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitive delivery order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, utilizes firm fixed pricing and carries no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $7,489.37 and an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the awardee's Conshohocken, Pennsylvania location. The award represents a competitively awarded transaction under AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs at a ceiling value of $1,249.34. This competitive award, which requires completion by August 26, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,766.06 to AmerisourceBergen Drug Corp for the supply of epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order was issued on September 16, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2-pack) on June 2, 2025, with a ceiling value of $7,584.92 and an ultimate completion date of June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The award represents a continuation of AmerisourceBergen's critical role in supplying pharmaceutical products and medical devices to support federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,094.00 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This non-set-aside, competitively awarded contract was issued on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen will perform this delivery order at its corporate office location in Conshohocken, Pennsylvania. The contract utilizes a firm fixed-price structure, reflecting the...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $23,293.20 delivery order on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a discrete fulfillment under AmerisourceBergen's...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBWDPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,895.87 to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Epinephrine 0.3 mg auto-injector kits (2-pack units). This is a firm fixed-price delivery order with an ultimate completion date of June 10, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support to military healthcare systems, enabling the supply of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA's procurement strategy for pharmaceutical support includes plans to establish multiple Pharmaceutical Prime Vendor Global Program Generation V contracts across separate regions, positioning AmerisourceBergen Drug Corp as a critical supplier serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 6/9/25 |